3-phenylpiperidine

Category:Articles with short descriptionCategory:Short description is different from Wikidata
3-Phenylpiperidine
Clinical data
ATC code
Identifiers
  • 3-phenylpiperidine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.021.458 Edit this at WikidataCategory:ECHA InfoCard ID from Wikidata#*
Chemical and physical data
FormulaC11H15N
Molar mass161.248 g·mol−1
3D model (JSmol)
  • C1CC(CNC1)C2=CC=CC=C2
  • InChI=1S/C11H15N/c1-2-5-10(6-3-1)11-7-4-8-12-9-11/h1-3,5-6,11-12H,4,7-9H2
  • Key:NZYBILDYPCVNMU-UHFFFAOYSA-N
Category:Chemical pages without DrugBank identifier#*Category:Articles without KEGG source#*Category:Articles without UNII source#*Category:Drugs with no legal statusCategory:Articles containing unverified chemical infoboxes#*

3-Phenylpiperidine is a chemical compound and cyclized phenethylamine.[1] It can be thought of as β-phenethylamine with a propyl group connecting the amine and the β position.[1]

According to Daniel Trachsel and colleagues in 2013, the pharmacology of 3-phenylpiperidine itself has not been reported, only its chemical synthesis has been described.[1][2] 3-Phenylpiperidine was first described in the scientific literature by 1933.[1][2]

Derivatives

3-Phenylpiperidine is a parent compound of several drugs such as the psychedelic and related drugs LPH-5 ((S)-2C-TFM-3PIP),[3] 2C-B-3PIP, 2C-B-3PIP-NBOMe, 2C-B-3PIP-POMe, 2T-2CTFM-3PIP, and Z3517967757 (Z7757),[4] the antipsychotic OSU-6162,[5] and the sigma receptor agonist 3-PPP.[1]

See also

References

  1. 1 2 3 4 5 Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226. Das Piperidinring-Positionsisomer 3-Phenylpiperidin (68) enthält die Phenethylamin-Substruktur. Es wurde bis anhin nur synthetisch beschrieben [56]. Das Derivat 69 ist unter dem Namen 3-PPP bekannt. Es ist für seine Affinität zum Sigma-Rezeptor bekannt und wurde Z.B. daraufhin untersucht, inwieweit es die antikonvulsive Wirkung von herkömmlichen Antiepileptika beeinflusst [97]. Zudem bindet es an Dopamin D2-Rezeptoren [98]. Das (+)-Enantiomer wirkt schwach agonistisch und das (-)-Enantiomer antagonistisch [98].Category:CS1 German-language sources (de)
  2. 1 2 Walters LA, McElvain SM (1933). "Piperidine Derivatives. XIII. Phenyl and Phenylalkyl Substituted Piperidinopropyl Benzoates". Journal of the American Chemical Society. 55 (11): 4625–4629. Bibcode:1933JAChS..55.4625W. doi:10.1021/ja01338a049. ISSN 0002-7863. Retrieved 13 July 2025.
  3. ↑ M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL (May 2024). "Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists". Journal of Medicinal Chemistry. 67 (9): 7224–7244. doi:10.1021/acs.jmedchem.4c00082. PMC 11089506. PMID 38648420.
  4. ↑ Lyu J, Kapolka N, Gumpper R, Alon A, Wang L, Jain MK, et al. (June 2024). "AlphaFold2 structures guide prospective ligand discovery". Science. 384 (6702) eadn6354. New York, N.Y. Bibcode:2024Sci...384n6354L. doi:10.1126/science.adn6354. PMC 11253030. PMID 38753765.
  5. ↑ Natesan S, Svensson KA, Reckless GE, Nobrega JN, Barlow KB, Johansson AM, et al. (August 2006). "The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat". The Journal of Pharmacology and Experimental Therapeutics. 318 (2): 810–818. doi:10.1124/jpet.106.102905. PMID 16648369.


Category:3-Phenylpiperidines